NIMBLE Study
Enrolling Now!

Talk to your doctor now about the NIMBLE clinical study

NIMBLE Study
Enrolling Now!

Talk to your doctor now about the NIMBLE clinical study

Does Myasthenia Gravis Continue to Affect Your Daily Life Despite Treatment?

Myasthenia gravis (MG) is a rare autoimmune disorder caused by autoantibodies produced by the immune system that attack the body’s own cells. These autoantibodies activate a pathway in the immune system called the complement pathway that disrupts the communication between nerves and muscles, so that the muscle cannot function normally.

Does Myasthenia Gravis Continue to Affect Your Daily Life Despite Treatment?

Myasthenia gravis (MG) is a rare autoimmune disorder caused by autoantibodies produced by the immune system that attack the body’s own cells. These autoantibodies activate a pathway in the immune system called the complement pathway that disrupts the communication between nerves and muscles, so that the muscle cannot function normally.
This website provides information about a clinical study, NIMBLE, for adults with generalized myasthenia gravis (gMG).

Clinical studies are essential to investigating and developing potential treatments and are not possible without the volunteers who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of gMG, which may help others in the future with this condition.

Learn more about NIMBLE and see if it may be an option for you or someone you know!

This website provides information about a clinical study, NIMBLE, for adults with generalized myasthenia gravis (gMG).

Clinical studies are essential to investigating and developing potential treatments and are not possible without the volunteers who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of gMG, which may help others in the future with this condition.

Learn more about NIMBLE and see if it may be an option for you or someone you know!

en_USEnglish (United States)